Insider filing · TARS
Aziz Mottiwala
Chief Commercial Officer
profile →
Tarsus Pharmaceuticals, Inc.
TARS · Healthcare · 35 filings in 24 months
ticker →
Aziz Mottiwala sold $766K of Tarsus Pharmaceuticals (TARS)
Executed Jun 9 2025, disclosed Jun 11 2025, 2 days later.
Value, as filed
$766K
17,500 sh × $43.76
Executed
Jun 9 2025
the trade date, as filed
Disclosed
Jun 11 2025
2 days after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
AMAziz Mottiwala (Chief Commercial Officer) filed 1 Form 4 report in the trailing twelve months (0 purchases, 1 sale), most often in Tarsus Pharmaceuticals, Inc. (TARS). The largest single filing was $893K of TARS (13,056 sh across 3 lots, as filed), executed Mar 17.
The name
TARSHealthcare · Tarsus Pharmaceuticals, Inc., a commercial stage biopharmaceutical company, focuses on the development and commercialization of therapeutic…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→Other filings by Aziz Mottiwala in TARS
TARSSALE
Tarsus Pharmaceuticals, Inc.
$893K13,056 sh across 3 lots
Exec Mar 17
Filed Mar 19 · 5:30 PM ET TARSSALE Tarsus Pharmaceuticals, Inc. $506K
10,565 sh across 3 lots
Exec Mar 18 2025
Filed Mar 20 2025 · 5:30 PM ET